Physician profile
Kamel Sadat
NPI 1013189281
$13,797.76
in general payments reported to CMS, 2019-2025
36 companies · $131 in 2025
The $131 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $887 · 2020: $887 · 2021: $1,758 · 2022: $2,389 · 2023: $1,981 · 2024: $5,765 · 2025: $131.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,576 · Food and Beverage: $2,301.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,575.90 |
| Food and Beverage | $2,301.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $3,637.40 | 2022-2024 | Ruby Coil, Indigo System |
| Bard Peripheral Vascular, INC. | $1,631.39 | 2020-2024 | Crosser Iq, Rotarexs 6 F X 135 Cm, Covera |
| Boston Scientific Corporation | $957.14 | 2021-2023 | Watchman Flx, Watchman Access System |
| Cook Incorporated | $946.15 | 2024 | Cook Celect |
| Inari Medical, INC. | $925.02 | 2023-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Novartis Pharmaceuticals Corporation | $692.26 | 2019-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $629.11 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $513.72 | 2019-2024 | Xarelto |
| Abiomed | $411.28 | 2022-2024 | Impella |
| Abbott Laboratories | $398.64 | 2020-2024 | Cardiomems |
| Boehringer Ingelheim Pharmaceuticals, INC. | $380.45 | 2019-2023 | Jardiance |
| Cook Medical LLC | $350.72 | 2024 | Cook Celect |
| Shockwave Medical, INC | $319.32 | 2021-2022 | |
| Amgen INC. | $272.51 | 2019-2024 | Repatha |
| W. L. Gore & Associates, INC. | $254.09 | 2021-2022 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $203.49 | 2021 | |
| Chiesi USA, INC. | $164.38 | 2021-2023 | Cleviprex, Kengreal |
| Itamar Medical INC | $125.00 | 2023 | Watchpatone |
| Asahi Intecc USA, INC. | $119.79 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $106.72 | 2019-2024 | Eliquis, Camzyos |
| Merck Sharp & Dohme LLC | $104.97 | 2021-2023 | Verquvo |
| Sanofi-Aventis U.S. LLC | $95.70 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $90.14 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $84.26 | 2020-2021 | |
| Regeneron Healthcare Solutions, INC. | $63.58 | 2019 | |
| Astellas Pharma US INC | $48.31 | 2020-2021 | |
| Pfizer INC. | $47.05 | 2019-2020 | |
| Baxter Healthcare | $45.54 | 2025 | Biopharma Sol - Contract Manuf |
| Esperion Therapeutics, INC. | $31.14 | 2020-2021 | |
| Cvrx, INC. | $26.07 | 2024 | Barostim Neo System |
| Terumo Medical Corporation | $25.91 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $22.98 | 2024 | Arcalyst |
| Scpharmaceuticals INC. | $21.15 | 2024 | |
| Novo Nordisk INC | $20.60 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $16.64 | 2021 | |
| Cardiva Medical, INC. | $15.14 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kamel Sadat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.